First Time Loading...

CVS Health Corp
NYSE:CVS

Watchlist Manager
CVS Health Corp Logo
CVS Health Corp
NYSE:CVS
Watchlist
Price: 55.9 USD 1.36% Market Closed
Updated: May 4, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Income Statement

360.9B
+0.9%
Revenue
Growth Rates:
1 Year
+9%
3 Years
+33%
5 Years
+71%
7 Years
+102%
10 Years
+181%
13.6B
-10%
Operating Income
Growth Rates:
1 Year
-15%
3 Years
-4%
5 Years
+18%
7 Years
+45%
10 Years
+62%
7.3B
-12%
Net Income
Growth Rates:
1 Year
+84%
3 Years
-1%
5 Years
-
7 Years
+43%
10 Years
+54%

Earnings Waterfall
CVS Health Corp

Revenue
360.9B USD
Cost of Revenue
-307.3B USD
Gross Profit
53.6B USD
Operating Expenses
-40.1B USD
Operating Income
13.6B USD
Other Expenses
-6.2B USD
Net Income
7.3B USD

Income Statement
CVS Health Corp

Rotate your device to view
Income Statement
Currency: USD
Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
128 651
N/A
132 005
+3%
135 094
+2%
139 367
+3%
143 010
+3%
145 577
+2%
149 200
+2%
153 290
+3%
160 174
+4%
166 730
+4%
172 701
+4%
177 546
+3%
178 845
+1%
180 805
+1%
182 371
+1%
184 786
+1%
186 015
+1%
187 252
+1%
188 561
+1%
194 579
+3%
210 967
+8%
227 476
+8%
244 796
+8%
256 776
+5%
261 885
+2%
263 795
+1%
266 041
+1%
268 706
+1%
271 048
+1%
278 323
+3%
285 061
+2%
292 111
+2%
299 840
+3%
307 860
+3%
315 225
+2%
322 467
+2%
330 919
+3%
339 204
+3%
347 809
+3%
357 776
+3%
360 935
+1%
Gross Profit
Cost of Revenue
(104 510)
(107 381)
(110 029)
(114 000)
(117 421)
(119 910)
(123 340)
(126 762)
(133 066)
(139 009)
(144 149)
(146 533)
(148 005)
(150 054)
(151 995)
(153 448)
(153 010)
(153 127)
(153 565)
(156 447)
(153 790)
(153 884)
(154 819)
(158 719)
(161 819)
(163 091)
(163 594)
(163 981)
(164 528)
(167 806)
(171 877)
(239 991)
(180 418)
(186 188)
(191 542)
(267 965)
(223 286)
(249 314)
(275 136)
(303 345)
(307 318)
Gross Profit
24 141
N/A
24 624
+2%
25 065
+2%
25 367
+1%
25 589
+1%
25 667
+0%
25 860
+1%
26 528
+3%
27 108
+2%
27 721
+2%
28 552
+3%
31 013
+9%
30 840
-1%
30 751
0%
30 376
-1%
31 338
+3%
33 005
+5%
34 125
+3%
34 996
+3%
38 132
+9%
57 177
+50%
73 592
+29%
89 977
+22%
98 057
+9%
100 066
+2%
100 704
+1%
102 447
+2%
104 725
+2%
106 520
+2%
110 517
+4%
113 184
+2%
52 120
-54%
119 422
+129%
121 672
+2%
123 683
+2%
54 502
-56%
107 633
+97%
89 890
-16%
72 673
-19%
54 431
-25%
53 617
-1%
Operating Income
Operating Expenses
(15 782)
(16 029)
(16 378)
(16 568)
(17 203)
(17 227)
(16 814)
(17 074)
(17 601)
(18 677)
(19 015)
(20 627)
(21 505)
(20 862)
(20 812)
(21 619)
(23 264)
(23 907)
(24 703)
(27 962)
(45 720)
(61 284)
(77 270)
(85 590)
(86 870)
(86 157)
(87 838)
(90 751)
(92 455)
(96 836)
(99 026)
(36 889)
(103 911)
(105 958)
(107 712)
(38 212)
(91 771)
(74 867)
(57 718)
(39 345)
(40 055)
Selling, General & Administrative
(15 782)
(16 029)
(16 378)
(16 568)
(16 682)
(16 706)
(16 814)
(17 074)
(17 601)
(18 135)
(18 473)
(18 448)
(18 683)
(18 683)
(18 633)
(18 809)
(18 944)
(19 137)
(19 494)
(21 368)
(24 597)
(27 705)
(31 280)
(33 061)
(33 413)
(34 036)
(34 171)
(35 072)
(35 459)
(35 690)
(36 195)
(707)
0
0
0
(745)
0
0
0
(985)
0
Other Operating Expenses
0
0
0
0
(521)
(521)
0
0
0
(542)
(542)
(2 179)
(2 822)
(2 179)
(2 179)
(2 810)
(4 320)
(4 770)
(5 209)
(6 594)
(21 123)
(33 579)
(45 990)
(52 529)
(53 457)
(52 121)
(53 667)
(55 679)
(56 996)
(61 146)
(62 831)
(36 182)
(103 911)
(105 958)
(107 712)
(37 467)
(91 771)
(74 867)
(57 718)
(38 360)
(40 055)
Operating Income
8 359
N/A
8 595
+3%
8 687
+1%
8 799
+1%
8 386
-5%
8 440
+1%
9 046
+7%
9 454
+5%
9 507
+1%
9 044
-5%
9 537
+5%
10 386
+9%
9 335
-10%
9 889
+6%
9 564
-3%
9 719
+2%
9 741
+0%
10 218
+5%
10 293
+1%
10 170
-1%
11 457
+13%
12 308
+7%
12 707
+3%
12 467
-2%
13 196
+6%
14 547
+10%
14 609
+0%
13 974
-4%
14 065
+1%
13 681
-3%
14 158
+3%
15 231
+8%
15 511
+2%
15 714
+1%
15 971
+2%
16 290
+2%
15 862
-3%
15 023
-5%
14 955
0%
15 086
+1%
13 562
-10%
Pre-Tax Income
Interest Income Expense
(541)
(573)
(604)
(600)
(576)
(584)
(692)
(838)
(986)
(1 100)
(1 092)
(1 078)
(1 047)
(1 014)
(1 006)
(1 062)
(1 333)
(1 775)
(2 204)
(2 619)
(3 363)
(3 446)
(3 519)
(3 035)
(2 986)
(2 979)
(2 963)
(2 907)
(2 831)
(2 702)
(2 573)
(2 503)
(2 432)
(2 379)
(2 343)
(2 287)
(2 290)
(2 393)
(2 520)
(2 658)
(2 785)
Non-Reccuring Items
0
0
(521)
(521)
0
0
0
0
0
0
(101)
(643)
0
(236)
(135)
(181)
0
(3 967)
(3 967)
(6 149)
(6 257)
(2 403)
(2 527)
(559)
(520)
(523)
(951)
(1 503)
(1 475)
(1 445)
(1 707)
(2 373)
(2 857)
(2 817)
(9 703)
(8 336)
(8 160)
(8 656)
(967)
(1 343)
(994)
Total Other Income
0
0
0
0
0
0
0
0
(9)
0
(7)
(28)
(10)
(26)
(211)
(208)
(204)
(200)
(9)
4
38
72
104
124
147
161
184
206
202
202
197
182
174
172
164
169
149
128
109
88
91
Pre-Tax Income
7 818
N/A
8 022
+3%
7 562
-6%
7 678
+2%
7 810
+2%
7 856
+1%
8 354
+6%
8 616
+3%
8 512
-1%
7 944
-7%
8 337
+5%
8 637
+4%
8 278
-4%
8 613
+4%
8 212
-5%
8 268
+1%
8 204
-1%
4 276
-48%
4 113
-4%
1 406
-66%
1 875
+33%
6 531
+248%
6 765
+4%
8 997
+33%
9 837
+9%
11 206
+14%
10 879
-3%
9 770
-10%
9 961
+2%
9 736
-2%
10 075
+3%
10 537
+5%
10 396
-1%
10 690
+3%
4 089
-62%
5 836
+43%
5 561
-5%
4 102
-26%
11 577
+182%
11 173
-3%
9 874
-12%
Net Income
Tax Provision
(3 047)
(3 130)
(2 977)
(3 033)
(3 073)
(3 093)
(3 302)
(3 386)
(3 356)
(3 136)
(3 224)
(3 317)
(3 143)
(3 305)
(3 161)
(3 137)
(3 037)
(2 768)
(2 500)
(2 102)
(2 142)
(2 305)
(2 400)
(2 366)
(2 621)
(2 935)
(2 918)
(2 569)
(2 548)
(2 518)
(2 489)
(2 548)
(2 409)
(2 533)
(928)
(1 509)
(1 567)
(1 155)
(2 956)
(2 805)
(2 524)
Income from Continuing Operations
4 771
4 892
4 585
4 645
4 737
4 763
5 052
5 230
5 156
4 808
5 113
5 320
5 135
5 308
5 051
5 131
5 167
1 508
1 613
(696)
(267)
4 226
4 365
6 631
7 216
8 271
7 961
7 201
7 413
7 218
7 586
7 989
7 987
8 157
3 161
4 327
3 994
2 947
8 621
8 368
7 350
Income to Minority Interest
0
0
0
0
0
0
(1)
(2)
(3)
(3)
(3)
(2)
(2)
(2)
(1)
(1)
(2)
(2)
0
2
(4)
1
0
3
3
(13)
(8)
(13)
(9)
(6)
0
12
12
10
(8)
(16)
(21)
(24)
(21)
(24)
(29)
Net Income (Common)
4 763
N/A
4 885
+3%
4 584
-6%
4 644
+1%
4 736
+2%
4 762
+1%
5 060
+6%
5 237
+3%
5 156
-2%
4 803
-7%
5 091
+6%
5 291
+4%
5 108
-3%
5 283
+3%
5 031
-5%
6 606
+31%
6 647
+1%
2 990
-55%
3 097
+4%
(597)
N/A
(175)
+71%
4 323
N/A
4 464
+3%
6 634
+49%
7 222
+9%
8 262
+14%
7 956
-4%
7 179
-10%
7 395
+3%
7 203
-3%
7 577
+5%
8 001
+6%
7 999
0%
8 167
+2%
3 153
-61%
4 311
+37%
3 973
-8%
2 923
-26%
8 600
+194%
8 344
-3%
7 321
-12%
EPS (Diluted)
4
N/A
4.16
+4%
3.93
-6%
3.97
+1%
4.16
+5%
4.2
+1%
4.51
+7%
4.64
+3%
4.69
+1%
4.49
-4%
4.74
+6%
4.9
+3%
4.93
+1%
5.15
+4%
4.93
-4%
6.45
+31%
6.52
+1%
2.93
-55%
3.03
+3%
-0.57
N/A
-0.13
+77%
3.32
N/A
3.42
+3%
5.08
+49%
5.52
+9%
6.29
+14%
6.05
-4%
5.47
-10%
5.59
+2%
5.42
-3%
5.7
+5%
6.02
+6%
6.02
N/A
6.18
+3%
2.39
-61%
3.26
+36%
3.07
-6%
2.28
-26%
6.66
+192%
6.47
-3%
5.77
-11%

See Also

Summary
CVS intrinsic value, competitors valuation, and company profile.
DCF Valuation
CVS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CVS stock valuation using valuation multiples.
Wall Street Estimates
CVS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CVS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.